Latest filing published 05 Jun 2026 for Sarepta Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Michael Andrew Chambers: trading record in brief
This profile gathers the share dealings of Michael Andrew Chambers in Sarepta Therapeutics, Inc., where the filings describe the role as board member. We count 19 filings; the first trade dates from 2 June 2022 and the latest from 4 June 2026.
The open-market record is one-sided, with 14 purchases worth €22.1M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants.
A typical purchase (the median) is worth €1.1M. None of the 14 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 5 June 2026 came the latest disclosure, a share grant in Sarepta Therapeutics, Inc. The latest purchase dates back some time: it was published 811 days ago, on 20 August 2024. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Andrew Chambers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,875 sharesCommon StockSEC:0001193125-26-260246:0
- 2,383 sharesCommon StockSEC:0000950170-25-037531:0
- 13,106 shares@ US$133.0714.2% of flowCommon StockSEC:0000950170-24-098859:0Canonical exit: 14 Nov 2024 (T+90)
- 1,846 shares0Common StockSEC:0000950170-24-026613:0
- 5,947 shares@ US$109.195.3% of flowCommon StockSEC:0001209191-23-045766:0Canonical exit: 12 Nov 2023 (T+90)
- 23,686 shares@ US$108.0520.8% of flowCommon StockSEC:0001209191-23-045498:0Canonical exit: 9 Nov 2023 (T+90)
- 2,206 shares@ US$104.671.9% of flowCommon StockSEC:0001209191-23-045366:0Canonical exit: 8 Nov 2023 (T+90)
- 1,523 shares0Common StockSEC:0001209191-23-017406:0
- 20,744 shares@ US$103.8719.3% of flowCommon StockSEC:0001209191-22-050002:0Canonical exit: 13 Dec 2022 (T+90)
- 40,110 shares@ US$108.2038.5% of flowCommon StockSEC:0001209191-22-046973:0Canonical exit: 17 Nov 2022 (T+90)
- 4,908 shares0Common StockSEC:0001209191-22-034739:0
11 of 11 declarations
